Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 153

1.

Oral mucosa lesions in hypereosinophilic syndrome--an update.

Ionescu MA, Murata H, Janin A.

Oral Dis. 2008 Mar;14(2):115-22. doi: 10.1111/j.1601-0825.2007.01393.x. Epub 2008 Jan 10. Review.

PMID:
18194138
2.

Hypereosinophilic syndrome and proliferative diseases.

Ionescu MA, Wang L, Janin A.

Acta Dermatovenerol Croat. 2009;17(4):323-30. Review.

PMID:
20021987
3.

Hypereosinophilic syndromes.

Roufosse FE, Goldman M, Cogan E.

Orphanet J Rare Dis. 2007 Sep 11;2:37. Review.

4.

[The idiopathic hypereosinophilic syndrome and chronic eosinophilic leukemia].

Chrobák L, Voglová J.

Vnitr Lek. 2005 Dec;51(12):1385-93. Review. Czech.

PMID:
16430106
5.

Hypereosinophilic syndrome: case presentation and update.

Leiferman KM, Gleich GJ.

J Allergy Clin Immunol. 2004 Jan;113(1):50-8.

PMID:
14713907
6.

[Isolated mucosal ulcers disclosing idiopathic hypereosinophilic syndrome].

Billon C, Gautier C, Villaret E, Ducos MH, Martin JC, Geniaux M.

Ann Dermatol Venereol. 1997;124(3):248-50. French.

PMID:
9686058
7.

Hypereosinophilic syndrome: an update.

Wilkins HJ, Crane MM, Copeland K, Williams WV.

Am J Hematol. 2005 Oct;80(2):148-57. Review.

9.

Eosinophilic disorders: molecular pathogenesis, new classification, and modern therapy.

Gotlib J, Cross NC, Gilliland DG.

Best Pract Res Clin Haematol. 2006;19(3):535-69. Review.

PMID:
16781488
10.

Successful treatment of myeloid neoplasms associated with PDGFRA rearrangement with imatinib mesylate.

Sun CY, Hu Y, Chu ZB, Guo T, He J.

Int J Hematol. 2009 Jan;89(1):66-70. doi: 10.1007/s12185-008-0205-1. Epub 2008 Dec 20.

PMID:
19096755
11.

[Idiopathic hypereosinophilic syndrome: toward a new molecular-targeted therapy and a new cytomorphological and molecular definition].

Moles MP, Landry J, Roche-Lestienne C, Godon A, Schmidt-Tanguy A, Gardembas M, Le Clech C, Verret JL, Zandecki M, Blanchet O.

Ann Biol Clin (Paris). 2005 May-Jun;63(3):317-22. French.

12.

Response of idiopathic hypereosinophilic syndrome to treatment with imatinib mesylate.

Ault P, Cortes J, Koller C, Kaled ES, Kantarjian H.

Leuk Res. 2002 Sep;26(9):881-4.

PMID:
12127565
13.

Lymphocytic variant hypereosinophilic syndromes.

Roufosse F, Cogan E, Goldman M.

Immunol Allergy Clin North Am. 2007 Aug;27(3):389-413. Review.

PMID:
17868856
14.

The hypereosinophilic syndromes: still more heterogeneity.

Gleich GJ, Leiferman KM.

Curr Opin Immunol. 2005 Dec;17(6):679-84. Epub 2005 Oct 7. Review.

PMID:
16214314
15.

Imatinib: new indication. New indications, but not robust evidence.

[No authors listed]

Prescrire Int. 2008 Jun;17(95):91-4.

PMID:
18623899
16.

Bullous pemphigoid associated with hypereosinophilic syndrome: simultaneous response to imatinib.

Hofmann SC, Technau K, Müller AM, Lübbert M, Bruckner-Tuderman L.

J Am Acad Dermatol. 2007 May;56(5 Suppl):S68-72. Epub 2006 Aug 28. Review.

PMID:
17097375
17.

Mucosal ulcerations revealing primitive hypereosinophilic syndrome.

Barouky R, Bencharif L, Badet F, Salles G, Vital Durand D, Rousset H.

Eur J Dermatol. 2003 Mar-Apr;13(2):207-8.

PMID:
12695143
18.

Idiopathic hypereosinophilic syndrome: a case evolving in B-lymphoblastic lymphoma.

Rapanotti MC, Caruso R, Bernardini S, Coletti V, Lo-Coco F, De Rossi G.

Leuk Res. 2005 Aug;29(8):975-9. Epub 2005 Mar 2.

PMID:
15978951
19.

Hypereosinophilic syndrome: diagnosis and treatment.

Peros-Golubicić T, Smojver-Jezek S.

Curr Opin Pulm Med. 2007 Sep;13(5):422-7. Review.

PMID:
17940488
20.

Hypereosinophilic syndrome - lymphocytic variant transforming into peripheral T-cell lymphoma with severe oral manifestations.

d'Elbée JM, Parrens M, Mercié P, Longy Boursier M, Dieval C, de Mascarel A, Duffau P, Dubus P, Fricain JC.

Oral Surg Oral Med Oral Pathol Oral Radiol. 2013 Sep;116(3):e185-90. doi: 10.1016/j.oooo.2013.03.017. Epub 2013 May 10.

PMID:
23669204

Supplemental Content

Support Center